Eris Lifesciences

Eris Lifesciences

ERIS

 ₹ 1,274.80
- ₹ 24.56
1.89%
Healthcare
 ₹ 0.00
(%)1D
Updated: 27 Mar 2025, 09:32:06 am IST
Stock Score
Open Price
 ₹ 1,296.96
Prev. Close
 ₹ 1,299.36
 ₹ 1,243.11
Day Low
 ₹ 1,299.10
Day High

 ₹ 818.80
52 Week Low
 ₹ 1,579.02
52 Week High

Quick Bite

Price To Earnings Ratio

44.23

Sector PE

63.19

PB Ratio

6.72

Sector PB

8.18

EPS

28.82

Dividend Yield

0.00

Today's Volume

35.169 K

5 Day Avg. Volume

451.645 K

PEG Ratio

17.41

Market Cap.

₹ 18,940.00 Cr.

News & Events

About Eris Lifesciences

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD) and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women's health, central nervous system (CNS), oncology and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.

Eris Lifesciences Share Price

Eris Lifesciences Limited is an Indian company primarily engaged in the production and distribution of pharmaceutical products. The company's manufacturing facility is located in Guwahati, Assam. Its therapeutic areas include oral diabetes, cardiac, pain/analgesic, gynecology, gastrointestinal, central nervous system (CNS) and vitamins, minerals and nutrients (VMN). The company's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cybex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The company's 100% subsidiaries are Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

Eris Lifesciences FAQs

How to Buy Eris Lifesciences Share?

up
To purchase Eris Lifesciences shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Eris Lifesciences (ticker symbol: ERIS) on the trading platform provided by your broker and purchase the shares.

What's Eris Lifesciences share price today?

up
The stock price of Eris Lifesciences as of 04 Apr 2025 is ₹1,274.80

What is the Market Cap of Eris Lifesciences?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 04 Apr 2025, Eris Lifesciences (ticker symbol: ERIS) has a market capitalisation of approximately ₹1,89,40,00,00,000.00

What is the PE and PB ratio of Eris Lifesciences?

up
Eris Lifesciences Ltd's price-to-book ratio as of 04 Apr 2025 is 6.72, reflecting the market's valuation compared to its asset value. As of 04 Apr 2025, the trailing twelve months P/E (price-to-earnings) ratio is 44.23, indicating the market values the company at around ₹44.23 for every ₹1 of earnings

What is the 52 Week High and Low of Eris Lifesciences Share?

up
Eris Lifesciences Ltd (ERIS) hit its 52-week high at ₹1,579.02, and its 52-week low at ₹818.80.
Begin your investment journey today
Login/Register
Start Now